Tao Sai
About Tao Sai
Title and Role at Bristol-Myers Squibb
Tao Sai is the Hybridoma Leader and Associate Director in the Department of Antibody Generation at Bristol-Myers Squibb. Stationed in Redwood City, California, Tao is responsible for overseeing antibody generation using hybridoma technology. This role involves leading research initiatives, managing a team of scientists, and contributing to the development of innovative biotherapeutics.
Previous Experience at Pfizer
Before his current role, Tao Sai worked at Pfizer from 2014 to 2019. During his five-year tenure as Associate Research Fellow, Biotherapeutic Design & Discovery, he was based in South San Francisco, CA. His responsibilities included designing and discovering biotherapeutic agents, which involved a range of cellular and molecular biology techniques.
Past Role at Genentech
From 2007 to 2014, Tao Sai served as the Scientific Manager of Antibody Engineering at Genentech in South San Francisco, CA. For seven years, he led antibody engineering projects, which required extensive expertise in cellular and molecular biology. His role involved overseeing the development of novel antibodies and improving existing technologies in the field.
Early Career at Morphotek, Inc. and Fox Chase Cancer Center
Tao Sai's earlier career includes positions at Morphotek, Inc. and Fox Chase Cancer Center. At Morphotek, Inc, from 2003 to 2006, he acted as the Group Leader for the Lead Discovery Group in the Greater Philadelphia Area. Previously, from 1999 to 2003, he was a Postdoctoral Research Associate at Fox Chase Cancer Center, where he contributed to various research projects in the field of cancer biology.
Educational Background in Immunology and Medicine
Tao Sai earned his Ph.D. in Immunology from Saga University, School of Medicine, where he studied from 1995 to 1999. He also holds an MD from Fujian Medical University. His educational background laid a strong foundation for his later work in antibody discovery and biotherapeutics.